Financials data is unavailable for this security.
View more
Year on year Oncosil Medical Ltd 's revenues fell -9.95% from 430.28k to 387.46k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 11.34m to a larger loss of 12.38m.
Gross margin | -256.87% |
---|---|
Net profit margin | -3,193.94% |
Operating margin | -3,114.06% |
Return on assets | -138.79% |
---|---|
Return on equity | -171.02% |
Return on investment | -170.28% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Oncosil Medical Ltd fell by 4.89m. Cash Flow from Financing totalled 6.23m or 1,609.19% of revenues. In addition the company used 11.13m for operations while cash from investing was breakeven.
Cash flow per share | -0.0057 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0014 |
---|---|
Tangible book value per share | 0.0014 |
More ▼
Balance sheet in AUDView more
Current ratio | 3.61 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0154 |
---|---|
Total debt/total capital | 0.0152 |
More ▼